Download Role of the Clinical Pharmacist as a Catalyst for Appropriate

523 ROUTE 303
ORANGEBURG, NY 10962
Role of the
Clinical Pharmacist
as a Catalyst for
Appropriate Antibiotic
Decision Making
Monday, December 5, 2011
5:30 PM- 8:00 PM
New Orleans Marriott
Find us on Facebook
555 Canal Street
New Orleans, LA
COMPLIMENTARY KNOWLEDGE-BASED
CPE DINNER SYMPOSIUM
Role of the Clinical Pharmacist
as a Catalyst for Appropriate
Antibiotic Decision Making
Monday, December 5, 2011
5:30 PM- 8:00 PM
New Orleans Marriott
555 Canal Street
New Orleans, LA
FACULTY
Michael J. Rybak, PharmD, MPH, FCCP, FIDSA (Chair)
Professor of Pharmacy and Medicine
Director, Anti-Infective Research Laboratory
Department of Pharmacy Practice
Eugene Applebaum College of Pharmacy
Wayne State University
Detroit, MI
Thomas M. File, Jr, MD, MSc, MACP, FIDSA, FCCP
Professor, Internal Medicine; Master Teacher
Chair, Infectious Disease Section
Northeast Ohio Medical University
Rootstown, OH
Chair, Infectious Disease Division
Summa Health System
Akron, OH
Joseph L. Kuti, PharmD
Associate Director, Clinical and Economic Studies
Center for Anti-Infective Research and Development
Hartford Hospital
Hartford, CT
A Symposium conducted at the 46th ASHP Midyear Clinical Meeting and Exhibition
Role of the Clinical Pharmacist as a Catalyst for Appropriate Antibiotic Decision Making
Monday, December 5, 2011 • 5:30 PM- 8:00 PM • New Orleans Marriott
A Symposium conducted at the 46th ASHP Midyear Clinical Meeting and Exhibition
Background
Community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin
structure infections (ABSSSI) lead to significant patient morbidity and mortality, and pose
a major economic burden to the healthcare system. Based on current evidence, achieving
optimal patient, bacteriologic, and economic outcomes depends on:
• Effective diagnosis and determination of individual risk factors for resistant
organisms and
• Selecting the most effective empiric antibiotic based on local data and current
clinical evidence, including appropriate use of newer agents
As integral members of the clinical team and key hospital committees, health-system
pharmacists are in a unique position to take a leadership role in educating other
healthcare professionals, establishing evidence-based clinical pathways, and setting
standards for optimal patient care and medication use for these serious infections.
Learning Objectives
After participating in this live knowledge-based activity, pharmacists should be able to:
• Develop an evidence-based approach for management of patients with CABP
that is based on current clinical evidence, quality measures (eg, CMS) and practice
guidelines, and that ensures optimal use of all available antibiotics.
• Develop an evidence-based approach for management of patients with ABSSSI
that is based on current clinical evidence and practice guidelines, and that ensures
optimal use of all available antibiotics.
• Recommend strategies and programs that foster appropriate use of antibiotics and
address CMS and other quality measures.
5:30 - 6:00 PM
Registration & Complimentary Dinner
6:00 - 6:10 PM
Chairman’s Welcome
6:10 - 6:40 PM
Optimizing Care for Patients with CABP
Thomas M. File
6:40 - 7:10 PM
Optimizing Treatment of ABSSSI: From Guesswork to Guidelines
Michael J. Rybak
7:10 - 7:40 PM
Appropriate Antibiotic Use in the Era of Antimicrobial Stewardship
Joseph L. Kuti
7:40 - 8:00 PM
Panel Discussion and Q&A
Moderated by Michael J. Rybak
REGISTRATION
Seating at the symposium is limited. Pre-registration is for planning purposes
only and seating will be available on a first-come, first-served basis.
If you would like to participate in this FREE CPE activity, please register by
choosing one of the following options:
1. Register online at www.paradigmmc.com/idcpe.shtml
2. Complete the form below and fax to 1-845-398-5108
3. Call toll-free: 1-877-252-5100, ext 28
REGISTRATION INFORMATION (please print clearly):
Name: ________________________________________________________________________
Target Audience
This live knowledge-based activity has been designed to meet the educational needs of
pharmacists practicing in a health-system setting.
Statement of Support
This activity is co-sponsored by the University of
North Carolina Eshelman School of Pharmacy and
Paradigm Medical Communications, LLC.
Agenda
Last 4 digits of SS# (for CPE tracking purposes): _________________________________________
Degree(s): _____________________________________________________________________
Organization: __________________________________________________________________
®
Continuing Education Credit
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for
Pharmacy Education as a provider of continuing pharmacy education.
This program, 0046-9999-11-331-L01-P will provide 2 contact hours or 0.2 CEUs for attending this live activity and
for completing an evaluation form. Credit statements will be mailed within 2-4 weeks to participants who have
completed the program evaluation.
Disclosure of Commercial Support
This CPE activity is supported by an educational grant
from Forest Laboratories, Inc.
Disclosure
In accordance with ACPE requirements on disclosure, information about relationships of presenters with
commercial interests (if any) will be included in materials distributed at the time of the activity.
Address: _______________________________________________________________________
City: _________________________________________State: ___________ZIP: ______________
Phone: ________________________________________________________________________
Fax: __________________________________________________________________________
E-mail: ________________________________________________________________________
Auxiliary Aids
If you need any of the auxiliary aids or services identified in the Americans with Disabilities Act in order to
attend this program, or if you have any other special needs, please call 845-398-5100.